Figure 1. Left: Photograph of NIR-II fluorescence imager (AlbertSurgicalTM). Middle: Imaging of gastric conduits in different spectral windows. Right: Intraoperative principal component analysis (PCA) ...
Removing a patient's tumor while sparing healthy tissue requires exquisite precision, but often surgeons must rely on their eyes and hands to determine where to cut. A team led by researchers from ...
A cross-disciplinary research team has, for the first time, successfully applied NIR-II (1,000–3,000 nm) fluorescence video imaging during esophagectomy—a complex surgical procedure involving the ...
An international collaboration of researchers developed two new complementary approaches for versatile but precise light intensity measurements in fluorescence imaging systems. Accurate measurements ...
LOS GATOS, Calif., May 22, 2023 /PRNewswire/ -- Orlucent, Inc., a company focused on clinical assessment of suspicious moles, today announced the U.S. Food and Drug Administration (FDA) has granted ...
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial In the article that accompanies this editorial, ...
If Orlucent Inc. has its way atypical moles in adults will soon give up their secrets to clinicians on the lookout for skin cancer, this after the Los Gatos, Calif.-based company received a U.S. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results